Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
Adaptor Proteins, Signal Transducing
/ genetics
Adolescent
Adult
Age Factors
Apolipoprotein B-100
/ genetics
Biomarkers
/ blood
Cardiovascular Diseases
/ diagnosis
Child
Child, Preschool
Cholesterol, LDL
/ blood
Cross-Sectional Studies
Europe
/ epidemiology
Female
Genetic Predisposition to Disease
Homozygote
Humans
Hyperlipoproteinemia Type II
/ blood
Male
Mexico
/ epidemiology
Middle Aged
Mutation
Phenotype
Proprotein Convertase 9
/ genetics
Receptors, LDL
/ genetics
Retrospective Studies
Risk Factors
South America
/ epidemiology
Young Adult
atherosclerosis
cardiovascular disease
cholesterol
hypercholesterolemia
phenotype
Journal
Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
8
8
2020
medline:
25
11
2020
entrez:
8
8
2020
Statut:
ppublish
Résumé
Characterize homozygous familial hypercholesterolemia (HoFH) individuals from Iberoamerica. Approach and Results: In a cross-sectional retrospective evaluation 134 individuals with a HoFH phenotype, 71 adults (age 39.3±15.8 years, 38.0% males), and 63 children (age 8.8±4.0 years, 50.8% males) were studied. Genetic characterization was available in 129 (96%). The majority (91%) were true homozygotes (true HoFH, n=79, 43.0% children, 46.8% males) or compound heterozygotes (compound heterozygous familial hypercholesterolemia, n=39, 51.3% children, 46.2% males) with putative pathogenic variants in the There was a high frequency of cardiovascular disease even in children. Phenotype and cardiovascular complications were heterogeneous and associated with the type of molecular defect.
Identifiants
pubmed: 32757650
doi: 10.1161/ATVBAHA.120.313722
doi:
Substances chimiques
APOB protein, human
0
Adaptor Proteins, Signal Transducing
0
Apolipoprotein B-100
0
Biomarkers
0
Cholesterol, LDL
0
LDLR protein, human
0
LDLRAP1 protein, human
0
Receptors, LDL
0
PCSK9 protein, human
EC 3.4.21.-
Proprotein Convertase 9
EC 3.4.21.-
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM